It has been demonstrated that serum IL-33 concentrations were significantly increased in patients with severe/critical COVID-19 compared to patients with mild/moderate disease, but all severe/critical patients were over 64.5 years old and 81.8% were male. This evidence concerns the gene IL33 and COVID-19.